Pfizer Volunteers Report Headaches, Hangover After First Shot
Volunteers complained of aches and pains. Meanwhile, Pfizer has reportedly sold 80% of the drug to rich countries.
After the Pfizer and BioNTech vaccine candidate was revealed to be 90 per cent effective, volunteers of the first shot have reported “severe” hangover-like symptoms of headaches, muscle pain and fever.
According to a report by The Daily Mail, several volunteers complained of aches and pains all over. Around 43,500 people in six countries are part of the large-scale phase 3 trials for the vaccine candidate.
44-year-old volunteer Glenn Deshields told The Daily Mail that while he did feel like he had a severe handover, the symptoms cleared up pretty quickly.
However, another volunteer, Carrie from Missouri, who received two shots said that the symptoms, post the second one, were more severe. These trials were double-blind, which meant that the volunteers did not know if they received a vaccine or a placebo. This is done to try and achieve the most unbiased results.
Pfizer Vaccine Already 80 Per Cent Sold to Riches Countries
An analysis from Global Justice Now, a UK-based campaign group revealed that Pfizer has already sold 80 per cent of their vaccine candidate to the richest countries - which is to say that 1 billion doses have been bought by rich governments that represent just 14 per cent of the world’s population, reported Anadolu Agency.
Equitable vaccine distribution would help prevent vaccine deaths around the world, especially in vulnerable countries with failing healthcare systems.
According to the analysis, the big buyers include the “European Union with 200 million doses and an option for a further 100 million, the UK with 40 million, and the US with 100 million and an option to buy another 500 million.”
Nick Dearden, the director of Global Justice Now said that richer governments are simultaneously buying up the limited vaccines in development and not allowing other countries to produce their own.
“On the one hand, the British government is helping limit supply of these drugs by insisting on global patent rules that prevent countries producing their own generic vaccines. You couldn’t get a clearer example of how unequal the pharmaceutical system is – some make billions of pounds, while many others die because they cannot afford treatments or there are no more left for them to buy. It’s got to change.””Nick Dearden, director of Global Justice Now
What happens to developing countries then? Where does India stand? Read here to find out.
(Subscribe to FIT on Telegram)
Subscribe To Our Daily Newsletter Now.